Hepion Pharmaceuticals, Inc

/Hepion Pharmaceuticals, Inc

FOLLOW-ON OFFERING: We are a biopharmaceutical company headquartered in Edison, New Jersey, focused on the development of pleiotropic drug therapy for treatment of chronic liver disease.

Symbol

Last Closing Price
$2.89

Shares
10,000,000

Anticipated Date
November 25, 2020

Underwriters

This offering is no longer available

To view the prospectus for , or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange